Skip to main content
. 2021 Feb 22;13(1 Suppl):1411S–1421S. doi: 10.1177/1947603521996023

Table 1.

Inclusion and Exclusion Criteria.

Inclusion Criteria Exclusion Criteria
Clinical studies reporting outcomes of arthroscopic BMS for nonprimary talar OCLs Data not interpretable
Levels I-IV clinical studies Combination of patient/treatment groups and/or no separate data per group
Five or more patients included Follow-up period <6 months
Peer-reviewed studies Patient overlap in different studies
Full-text available studies published in the English language Treatment option inappropriately described
Asymptomatic lesions
Level V evidence
Animal studies/cadaveric studies

BMS = bone marrow stimulation; OCL = osteochondral lesion.